Suppr超能文献

射频消融术后肾肿瘤的磁共振成像特征

Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation.

作者信息

Svatek Robert S, Sims Robert, Anderson J Kyle, Abdel-Aziz Khaled, Cadeddu Jeffrey A

机构信息

Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA.

出版信息

Urology. 2006 Mar;67(3):508-12. doi: 10.1016/j.urology.2005.09.046. Epub 2006 Feb 28.

Abstract

OBJECTIVES

The interpretation of radiographic findings in renal tumors treated with minimally invasive modalities, such as radiofrequency ablation (RFA), is critical for assessing treatment adequacy. Magnetic resonance imaging (MRI) is commonly used for patients with renal insufficiency or contrast allergy. Because the MRI experience with renal RFA is limited, we reviewed our experience and report the unique MRI characteristics of RFA-treated renal tumors.

METHODS

A single-institution database of renal RFA was reviewed to identify patients followed up with MRI. A radiologist and urologist retrospectively reviewed all MRI scans to identify the characteristic lesion findings after RFA.

RESULTS

Eleven patients (12 tumors) treated by RFA were followed up with MRI examinations. The mean follow-up was 10 months. The mean tumor size at ablation was 2.4 cm, with minimal reduction over time. Ablated lesions were characterized by high signal intensity on T1-weighted images, low signal intensity on T2-weighted images, and an absence of contrast enhancement. Of the patients treated by percutaneous RFA, 71% developed a characteristic peritumor halo, seen as a rim of low signal intensity on T1-weighted and T2-weighted images, surrounding a zone of perinephric fat just external to the ablated area. Two lesions demonstrated enhancement on the initial postablation MRI scan, indicating incomplete ablation.

CONCLUSIONS

The MRI characteristics of successfully ablated renal tumors include the absence of enhancement, minimal size reduction over time, and high and low signal intensity on T1-weighted and T2-weighted imaging, respectively. Knowledge of these findings can aid radiologists and urologists in correctly assessing the success of RFA for kidney lesions.

摘要

目的

对于接受诸如射频消融(RFA)等微创治疗的肾肿瘤,解读其影像学检查结果对于评估治疗是否充分至关重要。磁共振成像(MRI)常用于肾功能不全或对造影剂过敏的患者。由于肾RFA的MRI经验有限,我们回顾了我们的经验并报告了RFA治疗肾肿瘤独特的MRI特征。

方法

回顾了一个单机构肾RFA数据库,以确定接受MRI随访的患者。一名放射科医生和一名泌尿科医生回顾性地检查了所有MRI扫描,以确定RFA后特征性病变表现。

结果

11例(12个肿瘤)接受RFA治疗的患者接受了MRI检查随访。平均随访时间为10个月。消融时肿瘤平均大小为2.4 cm,随时间推移缩小不明显。消融后的病变在T1加权图像上表现为高信号强度,在T2加权图像上表现为低信号强度,且无强化。在接受经皮RFA治疗的患者中,71%出现特征性的肿瘤周围晕环,在T1加权和T2加权图像上表现为低信号强度的边缘,围绕着消融区域外的肾周脂肪区。2个病变在消融后的首次MRI扫描中出现强化,提示消融不完全。

结论

成功消融的肾肿瘤的MRI特征包括无强化、随时间推移大小缩小不明显,以及在T1加权和T2加权成像上分别表现为高信号强度和低信号强度。了解这些表现有助于放射科医生和泌尿科医生正确评估肾病变RFA的成功与否。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验